FGI-103-723

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFGI-103-723
Drug Alias NameFGI103723
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-2 inhibitors
TargetsCaspase-2
Therapy Area/IndicationsHemorrhagic Fever, EbolaVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFunctional Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFunctional Genetics Inc
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, EbolaVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A